Literature DB >> 12706375

Late-onset form of beta-electron transfer flavoprotein deficiency.

A Curcoy1, R K J Olsen, A Ribes, V Trenchs, M A Vilaseca, J Campistol, J H Osorio, B S Andresen, N Gregersen.   

Abstract

Multiple acyl-CoA-dehydrogenase deficiency (MADD) or glutaric aciduria type II (GAII) are a group of metabolic disorders due to deficiency of either electron transfer flavoprotein (ETF) or electron transfer flavoprotein ubiquinone oxidoreductase (ETF-QO). We report the clinical features and biochemical and molecular genetic analyses of a patient with a mild late-onset form of GAII due to beta-ETF deficiency. Biochemical data showed an abnormal urine organic acid profile, low levels of free carnitine, increased levels of C(10:1n-6), and C(14:1n-9) in plasma, and decreased oxidation of [9,10-3H]palmitate and [9,10-3H]myristate in fibroblasts, suggesting MAD deficiency. In agreement with these findings, mutational analysis of the ETF/ETFDH genes demonstrated an ETFB missense mutation 124T>C in exon 2 leading to replacement of cysteine-42 with arginine (C42R), and a 604_606AAG deletion in exon 6 in the ETFB gene resulting in the deletion of lysine-202 (K202del). The present report delineates further the phenotype of mild beta-ETF deficiency and illustrates that the differential diagnosis of GAII is readily achieved by mutational analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706375     DOI: 10.1016/s1096-7192(03)00024-6

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

Review 1.  A diagnostic algorithm for metabolic myopathies.

Authors:  Andres Berardo; Salvatore DiMauro; Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

2.  Lipid-storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency.

Authors:  R K J Olsen; M Pourfarzam; A A M Morris; R C Dias; I Knudsen; B S Andresen; N Gregersen; S E Olpin
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

3.  [Muscle weakness and early stages of liver failure in a 22-year-old man].

Authors:  D Scheicht; M L Werthmann; S Zeglam; J Holtmeier; W Holtmeier; J Strunk
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

4.  Newborn Screening for Glutaric Aciduria-II: The New England Experience.

Authors:  I Sahai; C L Garganta; J Bailey; P James; H L Levy; M Martin; E Neilan; C Phornphutkul; D A Sweetser; T H Zytkovicz; R B Eaton
Journal:  JIMD Rep       Date:  2013-11-05

5.  Cystic renal dysplasia as a leading sign of inherited metabolic disease.

Authors:  Felix Distelmaier; Markus Vogel; Ute Spiekerkötter; Klaus Gempel; Dirk Klee; Stefan Braunstein; Heinz-Peter Groneck; Ertan Mayatepek; Udo Wendel; Bernd Schwahn
Journal:  Pediatr Nephrol       Date:  2007-07-19       Impact factor: 3.714

6.  Human METTL20 methylates lysine residues adjacent to the recognition loop of the electron transfer flavoprotein in mitochondria.

Authors:  Virginie F Rhein; Joe Carroll; Jiuya He; Shujing Ding; Ian M Fearnley; John E Walker
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

7.  A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.

Authors:  Robin Chautard; Cécile Laroche-Raynaud; Anne-Sophie Lia; Pauline Chazelas; Paco Derouault; Franck Sturtz; Yasser Baaj; Alice Veauville-Merllié; Cécile Acquaviva; Frédéric Favreau; Pierre-Antoine Faye
Journal:  BMC Med Genomics       Date:  2020-01-29       Impact factor: 3.063

8.  Beneficial Effect of N-Carbamylglutamate in a Neonatal Form of Multiple Acyl-CoA Dehydrogenase Deficiency.

Authors:  Sinziana Stanescu; Amaya Belanger-Quintana; Carlos Alcalde Martin; Celia Pérez-Cerdá Silvestre; Begoña Merinero Cortés; Belen Gonzalez Pérez; Carmen Fernández García-Abril; Francisco Arrieta Blanco; Esperanza Palacios Valverde; Mercedes Martínez-Pardo Casanova
Journal:  Case Rep Pediatr       Date:  2020-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.